Literature DB >> 10942909

Epidermal cytokines in murine cutaneous irritant responses.

I Effendy1, H Löffler, H I Maibach.   

Abstract

Investigations on cytokines in skin irritancy or non-immunological irritant contact dermatitis (ICD) should improve our understanding of their complex mechanism. Numerous studies showed, however, that similar epidermal cytokines have been detected in irritant and allergic reactions, suggesting a lack of specific cytokines that clearly differentiate allergic from irritant reactions even though the pathomechanisms between allergic contact dermatitis (ACD) and ICD are distinguished. Recent data, however, indicate that some mediators may be restricted to allergic responses (contact hypersensitivity). This could provide the impetus to study their implication on irritant reactions. We overview the epidermal cytokines involved in irritant responses compared to those in contact hypersensitivity based on published results of studies using in vitro cell-cultured murine keratinocytes and in vivo murine models. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942909     DOI: 10.1002/1099-1263(200007/08)20:4<335::aid-jat698>3.0.co;2-l

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  9 in total

1.  An alternatively spliced IL-15 isoform modulates abrasion-induced keratinocyte activation.

Authors:  Tsung-Lin Lee; Mei-Ling Chang; Yu-Jei Lin; Ming-Hsun Tsai; Yi-Hsuan Chang; Che-Ming Chuang; Yun Chien; Tomasz Sosinowski; Chih-Hsiu Wang; Yi-Yuan Chen; Chien-Kuo Lee; Jau-Shiuh Chen; Li-Fang Wang; John T Kung; Chia-Chi Ku
Journal:  J Invest Dermatol       Date:  2015-01-23       Impact factor: 8.551

2.  Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research.

Authors:  Yu-Jei Lin; Tsung-Lin Lee; Chia-Chi Ku
Journal:  J Vis Exp       Date:  2017-04-19       Impact factor: 1.355

3.  A novel model of inflammatory pain in human skin involving topical application of sodium lauryl sulfate.

Authors:  L J Petersen; A M Lyngholm; L Arendt-Nielsen
Journal:  Inflamm Res       Date:  2010-04-01       Impact factor: 4.575

4.  Vaccinia virus inoculation in sites of allergic skin inflammation elicits a vigorous cutaneous IL-17 response.

Authors:  Michiko K Oyoshi; Abdallah Elkhal; Lalit Kumar; Jordan E Scott; Suresh Koduru; Rui He; Donald Y M Leung; Michael D Howell; Hans C Oettgen; George F Murphy; Raif S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

5.  Thioredoxin ameliorates cutaneous inflammation by regulating the epithelial production and release of pro-inflammatory cytokines.

Authors:  Hai Tian; Yoshiyuki Matsuo; Atsushi Fukunaga; Ryusuke Ono; Chikako Nishigori; Junji Yodoi
Journal:  Front Immunol       Date:  2013-09-09       Impact factor: 7.561

6.  Safer topical treatment for inflammation using 5α-tetrahydrocorticosterone in mouse models.

Authors:  Annalisa Gastaldello; Dawn E W Livingstone; Amber J Abernethie; Nicola Tsang; Brian R Walker; Patrick W F Hadoke; Ruth Andrew
Journal:  Biochem Pharmacol       Date:  2017-01-24       Impact factor: 5.858

7.  Elovl6 regulates mechanical damage-induced keratinocyte death and skin inflammation.

Authors:  Yoshiyuki Nakamura; Takashi Matsuzaka; Satoko Tahara-Hanaoka; Kazuko Shibuya; Hitoshi Shimano; Chigusa Nakahashi-Oda; Akira Shibuya
Journal:  Cell Death Dis       Date:  2018-12-05       Impact factor: 8.469

8.  Differences in itch and pain behaviors accompanying the irritant and allergic contact dermatitis produced by a contact allergen in mice.

Authors:  Zhe Zhang; Nathalie M Malewicz; Xiaoyun Xu; Jianhao Pan; Nina Kumowski; Tao Zhu; Steven G Shimada; Hong Nie; Robert H LaMotte
Journal:  Pain Rep       Date:  2019-09-11

Review 9.  Cytokines and chemokines in irritant contact dermatitis.

Authors:  Haur Yueh Lee; Marco Stieger; Nikhil Yawalkar; Masato Kakeda
Journal:  Mediators Inflamm       Date:  2013-11-25       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.